4//SEC Filing
Allen Daniel 4
Accession 0001683168-22-008706
CIK 0001157075other
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 4:05 PM ET
Size
5.7 KB
Accession
0001683168-22-008706
Insider Transaction Report
Form 4
Allen Daniel
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-12-28+125,000→ 125,000 totalExercise: $2.97From: 2022-12-28Exp: 2032-11-14→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the "2022 Plan"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022.
Documents
Issuer
PharmaCyte Biotech, Inc.
CIK 0001157075
Entity typeother
Related Parties
1- filerCIK 0001736605
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 4:05 PM ET
- Size
- 5.7 KB